Dr. Sreedhar Mandayam, Professor of Medicine and Nephrologist at the University of Texas MD Anderson Cancer Center, discusses the AFFINITY Study a Phase 2 basket trial to study the safety and efficacy of atrasentan in proteinuric glomerular diseases, including Alport syndrome. Learn more about the AFFINITY Study on the ASF website: https://alportsyndrome.org/forpatien...